Skip to main content
. 2014 Sep 25;16:443. doi: 10.1186/s13058-014-0443-5

Figure 3.

Figure 3

Biological effects and signalling pathways involving p130Cas/BCAR1 and Nedd9 in different breast cancer subtypes. (A) Estrogen receptor (ER)-positive breast cancer. (B) ErbB2-positive breast cancer. (C) Triple-negative breast cancer. PI3K, phosphoinositide 3-kinase; SRF, serum response factor; TGF, transforming growth factor.